Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape
Journal of Medicinal Chemistry · 11.04.2024 · 67 (7) · 5683-5698
DOI: 10.1021/acs.jmedchem.3c02332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 18.03.2024. Verfasst von Edward Price und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States. Hauptthemen laut MEDLINE: Proteolysis Targeting Chimera, Drug Discovery. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research and Development, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States.
ORCID-Profile: Edward Price, Philip B Cox, David DeGoey
Zitieren
APA
Price, E., Weinheimer, M., Rivkin, A., Jenkins, G., Nijsen, M., Cox, P. B., & DeGoey, D. (2024). Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape. Journal of Medicinal Chemistry, 67(7), 5683-5698. https://doi.org/10.1021/acs.jmedchem.3c02332
Vancouver
Price E, Weinheimer M, Rivkin A, Jenkins G, Nijsen M, Cox PB, et al. Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape. Journal of Medicinal Chemistry. 2024;67(7):5683-5698. doi:10.1021/acs.jmedchem.3c02332
BibTeX
@article{Price2024,
author = {Price, Edward and Weinheimer, Manuel and Rivkin, Alexey and Jenkins, Gary and Nijsen, Marjoleen and Cox, Philip B and DeGoey, David},
title = {Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {7},
pages = {5683--5698},
doi = {10.1021/acs.jmedchem.3c02332}
}
EUVIMED